CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zenith Drugs Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zenith Drugs Ltd
K No 72/5 Village Muradpura Depalpur
INDORE, 453001  India Ticker: ZENITHDRUGZENITHDRUG
Business Summary
Zenith Drugs Ltd is an India-based pharmaceutical company. The Company is mainly engaged in the business of manufacturing and trading medicine. The Company offers generics and formulations, including ORS powder, liquid orals, ointments, liquid externals, and capsules. Its liquid oral products include Vitamin B Complex Syrup, Iron + Folic Acid + Vitamin B12 Syrup, Multivitamin Syrup, Vitamin B Complex with L Lysine Syrup, Multivitamin Drops, Paracetamol Suspension 125 mg/5 ml, Protein with Vitamin B Complex Syrup, Antacid Suspension Each 5ml, Cold Syrup (Para Cetrizine Phenylephrine), Levosalbutamol Syrup 1mg/5 ml, and others. Its ointment products include Povidone Iodine Ointment 5% W/W, Povidone Iodine + Metronidazole Ointment, Clotrimazole Cream IP 1% w/w, Fucidic Acid Cream 2%, Gentamycin Sulphate Cream 0.1%W/W, and more. Its capsule products include Omeprazole Capsule 20 mg, Tetracycline Capsule Blister 250 mg, Chloramphenicol Capsule 500 mg, and more.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20253/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8742 Management consulting services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer NeerajPandey 58 9/1/2024 9/1/2024
Company Secretary and Compliance Officer SakshiBhawsar 30 9/16/2023 9/16/2023
Managing Director, Executive Director SandeepBhardwaj 47 9/1/2024 10/31/2003
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 182 (As of 3/31/2025)
Outstanding Shares: 17,148,800 (As of 9/30/2025)
Stock Exchange: NSE


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, May 30, 2026